1. Lidar M, Livneh A . Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007; 65: 318–324.
2. Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M et al. Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 1999; 26: 890–897.
3. Baykal Y, Saglam K, Taslipinar A, Inal A . Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 2003; 22: 99–101.
4. Oktem S, Yavuzsen TU, Sengül B, Akhunlar H, Akar S, Tunca M . Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. Clin Exp Rheumatol 2004; 22 (Suppl 34): 34–36.
5. Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Koné-Paut I . Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2011; 41: 265–271.